pubmed-article:15310987 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15310987 | lifeskim:mentions | umls-concept:C0022665 | lld:lifeskim |
pubmed-article:15310987 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
pubmed-article:15310987 | lifeskim:mentions | umls-concept:C0010408 | lld:lifeskim |
pubmed-article:15310987 | lifeskim:mentions | umls-concept:C0547070 | lld:lifeskim |
pubmed-article:15310987 | lifeskim:mentions | umls-concept:C2347883 | lld:lifeskim |
pubmed-article:15310987 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
pubmed-article:15310987 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
pubmed-article:15310987 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:15310987 | pubmed:dateCreated | 2004-8-16 | lld:pubmed |
pubmed-article:15310987 | pubmed:abstractText | Ablative treatments (cryoablation or radio frequency ablation) for renal cell carcinoma aim to decrease morbidity by treating renal tumors in situ, eliminating the need for extirpation. These technologies have potential for complications previously unassociated with renal tumor treatment. We identified complications associated with percutaneous and laparoscopic ablative treatment of renal tumors. | lld:pubmed |
pubmed-article:15310987 | pubmed:language | eng | lld:pubmed |
pubmed-article:15310987 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15310987 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15310987 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15310987 | pubmed:month | Sep | lld:pubmed |
pubmed-article:15310987 | pubmed:issn | 0022-5347 | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:KavoussiLouis... | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:MatsumotoEdwa... | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:SolomonStephe... | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:ShingletonW... | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:CadedduJeffre... | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:MoonTimothy... | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:SuLi-MingLM | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:NakadaStephen... | lld:pubmed |
pubmed-article:15310987 | pubmed:author | pubmed-author:JohnsonD... | lld:pubmed |
pubmed-article:15310987 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15310987 | pubmed:volume | 172 | lld:pubmed |
pubmed-article:15310987 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15310987 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15310987 | pubmed:pagination | 874-7 | lld:pubmed |
pubmed-article:15310987 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:meshHeading | pubmed-meshheading:15310987... | lld:pubmed |
pubmed-article:15310987 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15310987 | pubmed:articleTitle | Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. | lld:pubmed |
pubmed-article:15310987 | pubmed:affiliation | Division of Urology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA. | lld:pubmed |
pubmed-article:15310987 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15310987 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15310987 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15310987 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15310987 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15310987 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15310987 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15310987 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15310987 | lld:pubmed |